LSTA FY 2017 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$372,000

Operating Income

-$28M

Net Income

$23M

EPS (Diluted)

$38.43

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$63M

Total Liabilities

$13M

Stockholders' Equity

$51M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$35M	-100.0%
Gross Profit	-$372,000	$4M	-109.0%
Operating Income	-$28M	-$31M	+11.9%
Net Income	$23M	-$33M	+170.4%